Skip to main content

Peer Review reports

From: Cost-effectiveness of pegfilgrastim versus filgrastim for prevention of chemotherapy-induced febrile neutropenia in patients with lymphoma: a systematic review

Original Submission
31 Mar 2022 Submitted Original manuscript
2 Aug 2022 Reviewed Reviewer Report - Itziar Oyagüez
14 Nov 2022 Reviewed Reviewer Report
25 Nov 2022 Author responded Author comments - Girma Tekle Gebremariam
Resubmission - Version 2
25 Nov 2022 Submitted Manuscript version 2
28 Nov 2022 Author responded Author comments - Girma Tekle Gebremariam
Resubmission - Version 3
28 Nov 2022 Submitted Manuscript version 3
Publishing
5 Dec 2022 Editorially accepted
30 Dec 2022 Article published 10.1186/s12913-022-08933-z

You can find further information about peer review here.

Back to article page